Français
Position Statements
CAREB-ACCER’s comments in response to the CCTCC REB Accreditation Working Group Consultation
In May 2016, the REB Accreditation Working Group of the Canadian Clinical Trials Coordinating Centre (CCTCC) released its Draft [...]
Read MoreCAREB-ACCER Response to Draft RDM Policy – 2018
File: CAREB-ACCER Response to Draft RDM Policy – 2018
Read MoreCAREB-ACCER’s response to the U.S. Notice of Proposed Rulemaking (NPRM) – Federal Policy for the Protection of Human Subjects
In September, 2015, the U.S. Department of Health and Human Services (HHS) and fifteen other [...]
Read MoreHuman Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators
October 2011 – The CAREB Board of Directors recently filed comments to the Department of Health and Human [...]
Read MoreResponsible Conduct of Research (RCR)
September 2011 – The CAREB Board of Directors filed comments in response to the Tri-Agency’s proposed framework on [...]
Read MoreReporting of Unanticipated Problems including Adverse Events to Research Ethics Boards in Canada
July 2010 – CAREB issued their first guidance document Reporting of Unanticipated Problems including Adverse Events to [...]
Read More